These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15359792)

  • 1. [Mechanism of HCV cell entry mediated by envelope and receptor proteins].
    Nishioka T; Chayama K
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):195-8. PubMed ID: 15359792
    [No Abstract]   [Full Text] [Related]  

  • 2. [Candidate molecules for HCV receptor].
    Moriishi K; Limn CK; Matsuura Y
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):191-4. PubMed ID: 15359791
    [No Abstract]   [Full Text] [Related]  

  • 3. [Entry mechanisms of hepatitis C virus].
    Tani H; Matsuura Y
    Tanpakushitsu Kakusan Koso; 2007 Aug; 52(10 Suppl):1095-100. PubMed ID: 17824223
    [No Abstract]   [Full Text] [Related]  

  • 4. DC-SIGN: binding receptors for hepatitis C virus.
    Wang QC; Feng ZH; Nie QH; Zhou YX
    Chin Med J (Engl); 2004 Sep; 117(9):1395-400. PubMed ID: 15377434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. L-SIGN (CD209L) isoforms differently mediate trans-infection of hepatoma cells by hepatitis C virus pseudoparticles.
    Falkowska E; Durso RJ; Gardner JP; Cormier EG; Arrigale RA; Ogawa RN; Donovan GP; Maddon PJ; Olson WC; Dragic T
    J Gen Virol; 2006 Sep; 87(Pt 9):2571-2576. PubMed ID: 16894195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Development of HCV vaccine].
    Abe T; Moriishi K; Matsuura Y
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):139-42. PubMed ID: 15359780
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus.
    Lavillette D; Tarr AW; Voisset C; Donot P; Bartosch B; Bain C; Patel AH; Dubuisson J; Ball JK; Cosset FL
    Hepatology; 2005 Feb; 41(2):265-74. PubMed ID: 15660396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor.
    Bartosch B; Vitelli A; Granier C; Goujon C; Dubuisson J; Pascale S; Scarselli E; Cortese R; Nicosia A; Cosset FL
    J Biol Chem; 2003 Oct; 278(43):41624-30. PubMed ID: 12913001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus.
    Gardner JP; Durso RJ; Arrigale RR; Donovan GP; Maddon PJ; Dragic T; Olson WC
    Proc Natl Acad Sci U S A; 2003 Apr; 100(8):4498-503. PubMed ID: 12676990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro interaction between hepatitis C virus (HCV) envelope glycoprotein E2 and serum lipoproteins (LPs) results in enhanced cellular binding of both HCV E2 and LPs.
    Wunschmann S; Muller HM; Stipp CS; Hemler ME; Stapleton JT
    J Infect Dis; 2006 Oct; 194(8):1058-67. PubMed ID: 16991080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Low density lipoprotein receptor: a receptor related to hepatitis C virus].
    Cheng J; Li L
    Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):190-2. PubMed ID: 12681078
    [No Abstract]   [Full Text] [Related]  

  • 12. Another putative receptor for hepatitis C virus.
    Op De Beeck A; Dubuisson J
    Hepatology; 2003 Mar; 37(3):705-7. PubMed ID: 12627595
    [No Abstract]   [Full Text] [Related]  

  • 13. [CD81 Present status and prospect of HCV receptor].
    Liu MX; Wang FS
    Zhonghua Gan Zang Bing Za Zhi; 2002 Aug; 10(4):311-3. PubMed ID: 12223154
    [No Abstract]   [Full Text] [Related]  

  • 14. [DC-SIGN, a receptor for phlebovirus].
    Meier R; Helenius A; Lozach PY
    Med Sci (Paris); 2012 Jan; 28(1):16-8. PubMed ID: 22289819
    [No Abstract]   [Full Text] [Related]  

  • 15. Functional features of hepatitis C virus glycoproteins for pseudotype virus entry into mammalian cells.
    Meyer K; Basu A; Ray R
    Virology; 2000 Oct; 276(1):214-26. PubMed ID: 11022009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scavenger receptor class B type I and hepatitis C virus infection of primary tupaia hepatocytes.
    Barth H; Cerino R; Arcuri M; Hoffmann M; Schürmann P; Adah MI; Gissler B; Zhao X; Ghisetti V; Lavezzo B; Blum HE; von Weizsäcker F; Vitelli A; Scarselli E; Baumert TF
    J Virol; 2005 May; 79(9):5774-85. PubMed ID: 15827192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advancement of the study of the mechanisms of cells invades by HCV].
    Zhang N; Zhang J
    Wei Sheng Yan Jiu; 2008 Jan; 37(1):122-5. PubMed ID: 18421884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Structure and function of a novel scavenger receptor expressed in human endothelial cells].
    Adachi H; Tsujimoto M
    Tanpakushitsu Kakusan Koso; 1999 Jun; 44(8 Suppl):1282-6. PubMed ID: 10397017
    [No Abstract]   [Full Text] [Related]  

  • 19. A single point mutation in E2 enhances hepatitis C virus infectivity and alters lipoprotein association of viral particles.
    Tao W; Xu C; Ding Q; Li R; Xiang Y; Chung J; Zhong J
    Virology; 2009 Dec; 395(1):67-76. PubMed ID: 19793603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hepatitis C virus and its hepatic environment: a toxic but finely tuned partnership.
    Perrault M; Pécheur EI
    Biochem J; 2009 Oct; 423(3):303-14. PubMed ID: 19807698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.